Based on MSF’s field experience and needs, we are pushing for better coverage with existing vaccines like measles and for cheaper and better adapted versions of new vaccines.
MSF launches challenge to Pfizer's patent on the pneumonia vaccine in India
This is the first time a vaccine (biosimilar) patent has been challenged in India by a medical organisation, with the goal of millions more children being protected against deadly pneumonia.
Vaccines: The Issues
Help Us #AskPharma to Make Vaccines Affordable
MSF led a protest in front of Pfizer's world headquarters in New York City and attended the company's shareholders' meeting in New Jersey demanding they and GSK slash the price of pneumococcal vaccine in developing countries and disclose what they currently charge countries for the vaccine...
MSF welcomes GSK's decision to lower the price of the pneumonia vaccine for some of the world's most vulnerable children
MSF response to GSK announcement to reduce pneumonia vaccine price for humanitarian organisations